Skip to content

Drug interactions

Efavirenz + Irinotecan

Severity: Moderate

Efavirenz and Irinotecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Strong CYP3A4 inducers lower exposure to irinotecan and its active metabolite SN-38, which may reduce antitumor efficacy. Efavirenz is a moderate inducer, so the effect is smaller but still relevant.

What this interaction means in plain words

Efavirenz and Irinotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efavirenz belongs to Anti Virals; Irinotecan belongs to Oncology.

Evidence level: Moderate

Why it happens

CYP3A4 induction increases irinotecan metabolism to inactive oxidized metabolites.

What to do

Where possible, use an antiretroviral that does not induce CYP3A4. If it is continued, monitor tumor response and toxicity closely.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Irinotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Irinotecan?

MediHelp rates the interaction as moderate. Efavirenz and Irinotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Strong CYP3A4 inducers lower exposure to irinotecan and its active metabolite SN-38, which may reduce antitumor efficacy. Efavirenz is a moderate inducer, so the effect is smaller but still relevant.

How serious is the interaction between Efavirenz and Irinotecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible, use an antiretroviral that does not induce CYP3A4. If it is continued, monitor tumor response and toxicity closely.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in